Back to Resources
Market Highlights
- Companies in the COVID-19 therapeutics market advanced efforts through FDA approvals, new research, and public awareness campaigns.
- Genentech received FDA approval for an expanded indication of its treatment for hospitalized pediatric COVID-19 patients aged 2 and older who were receiving systemic corticosteroids and required oxygen support, ventilation, or ECMO.
- Invivyd pursued fast-track FDA approval for VYD2311 as a vaccine alternative and launched the SPEAR Study Group to explore monoclonal antibody treatments for long COVID.
- Pfizer addressed COVID-19 risks, seasonal surges, and treatment awareness through unbranded campaigns like “We Talk, We Rise,” which promoted community resilience, as well as branded ads for Paxlovid and the PAXCESS Co-Pay Program.
Questions about this SnapShot or other markets?
U.S. MARKETS
Christine Alongi
alongi@dtwresearch.com
GLOBAL MARKETS
Robin Cefalo
cefalo@dtwresearch.com
SOCIAL MEDIA MARKETS
Andrew Carney
carney@dtwresearch.com